Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kelsey Goodwin is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/31/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/31/2024 | MGNX | Buy Now | Macrogenics | $3.85 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 02/28/2024 | NUVL | Buy Now | Nuvalent | $77.90 | 27.09% | → $99 | Assumes | → Buy | Get Alert |
| 09/13/2023 | TSVT | Buy Now | 2seventy bio | $4.79 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 09/12/2023 | TSVT | Buy Now | 2seventy bio | $4.79 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 08/15/2023 | TSVT | Buy Now | 2seventy bio | $4.79 | 442.8% | $27 → $26 | Maintains | Buy | Get Alert |
| 06/20/2023 | ACLX | Buy Now | Arcellx | $62.60 | — | — | Maintains | Buy | Get Alert |
| 04/24/2023 | ACLX | Buy Now | Arcellx | $62.60 | -7.36% | $45 → $58 | Maintains | Buy | Get Alert |
| 10/31/2022 | LEGN | Buy Now | Legend Biotech | $57.79 | — | — | Initiates | → Neutral | Get Alert |
| 10/31/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $8.85 | — | — | Initiates | → Neutral | Get Alert |
| 10/31/2022 | IPSC | Buy Now | Century Therapeutics | $2.21 | 578.73% | → $15 | Initiates | → Buy | Get Alert |
| 10/31/2022 | ACLX | Buy Now | Arcellx | $62.60 | -42.5% | → $36 | Initiates | → Buy | Get Alert |
| 10/31/2022 | TSVT | Buy Now | 2seventy bio | $4.79 | 526.3% | → $30 | Initiates | → Buy | Get Alert |
